Organogenesis Holdings (ORGO) Depreciation and Depletion (2018 - 2025)
Organogenesis Holdings (ORGO) recorded quarterly Depreciation and Depletion of $4.1 million in Q4 2025, up 0.92% quarter-over-quarter from $4.0 million in Q3 2025, and up 12.48% on a YoY basis from $3.6 million in Q4 2024.
Organogenesis Holdings (ORGO) Depreciation and Depletion (2018 - 2025) Analysis & Trends
Organogenesis Holdings' Depreciation and Depletion history runs 8 years deep, the most recent figure standing at $4.1 million for Q4 2025.
- In Q4 2025, Depreciation and Depletion rose 12.48% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $15.3 million (up 12.11% YoY), while the FY2025 annual figure was $15.3 million, up 12.11% from the prior year.
- Depreciation and Depletion was $4.1 million for Q4 2025 at Organogenesis Holdings, up from $4.0 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $4.1 million in Q4 2025 to a low of $1.0 million in Q1 2021.
- Historically, Depreciation and Depletion has averaged $2.5 million across 5 years, with a median of $2.6 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion decreased 24.83% in 2022, then surged 100.0% in 2023.
- A 5-year view of Depreciation and Depletion shows it stood at $1.8 million in 2021, then decreased by 14.51% to $1.5 million in 2022, then jumped by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then gained by 12.48% to $4.1 million in 2025.
- The last three Depreciation and Depletion figures came in at $4.1 million (Q4 2025), $4.0 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Organogenesis Holdings | 317.58 Mn | 225.48 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.07 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.07 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | 2.54 Mn |
| Sep 30, 2023 | 2.54 Mn |